The board of directors of Natural Beauty Bio-Technology Limited announced that the current Chief Executive Officer of the Group, Mr. HSIAO Wen-Chung, alias Mark Shaw, has tendered his resignation as the Chief Executive Officer of the Group with effect from 9 July 2018 due to personal reasons. The Board announced that, with effect from 9 July 2018, Ms. YANG Shu-Hwa has been appointed as Interim Chief Executive Officer of the Group and will tentatively hold office as Chief Executive Officer. Ms. YANG had been working in Venus Concept Ltd. from 2015 to February 2018, an Israeli company which she had served as the Chief Executive Officer in PRC. Prior to this appointment, Ms. YANG was a vice-president of Shanghai Pharmaceutical Holding Co. Ltd. from 2012 to 2015. Prior to joining Shanghai Pharmaceutical Holding Co. Ltd., Ms. YANG had been working in AstraZeneca Pharmaceutical Co. Ltd., of which she had served as the senior vice-president & Chief Financial Officer in China & Hong Kong from 2006 to 2011 and the Chief Executive Officer in Taiwan from 2011 to 2012. Ms. YANG had been working at Avon Products (Australia) Pty. Ltd., Digital Equipment Corporation Ltd, Aventis Pharma S. A., AB InBev Co. Ltd. and Colgate-Palmolive (China) Co. Ltd. from 1984 to 2005.